

SS-31
$69.99 $49.99
SS-31 (Elamipretide) Mitochondria-Targeted Tetrapeptide Product Information
This is a specialized research product of SS-31 (also known as Elamipretide), a synthetic tetrapeptide, strictly intended For In Vitro Research Use Only — Not for Human or Veterinary Use.
Description & Application 🔬
Description: SS-31 is a synthetic tetrapeptide specifically designed to selectively target the inner mitochondrial membrane. It achieves this by binding to cardiolipin, a key phospholipid in the inner membrane.
Mechanism of Action: It is studied for its ability to stabilize mitochondrial structure and function when the cells are under oxidative stress.
Research Focus: SS-31 is widely researched for its potential to:
Improve mitochondrial bioenergetics.
Reduce reactive oxygen species (ROS).
Support cellular resilience in models of degenerative and metabolic dysfunction.
Application Context: The compound is actively studied in vitro for its effects on:
Mitochondrial membrane stabilization and bioenergetics.
Reduction of mitochondrial-derived ROS.
Cardiolipin interaction and protection.
Cellular energy production under stress or degeneration.
Specifications & Storage
Unit Size: 10mg (lyophilized powder, single vial)
Form: Crystalline lyophilized peptide
Molecular Weight: $\sim 751.97 \text{ Da}$
⚠️ Legal & Intended Use
Intended Use: This compound is intended strictly for in vitro laboratory research. It is not approved for use in humans or animals and must not be used in foods, drugs, supplements, or diagnostics.
Legal Disclaimer: This product has not been evaluated by the U.S. Food and Drug Administration (FDA). No claims are made regarding diagnosis, treatment, or prevention of disease. Use is restricted to qualified professionals in certified research environments.
Terms of Sale: The buyer confirms they are a qualified researcher or institution, accepting full responsibility for proper handling, storage, usage, and compliance with applicable laws. All sales are final.
Contact
Get in touch with our team today.
Connect
© 2025. All rights reserved.
